PSYENCE BIOMEDICAL LTD. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. NOTABLESCHEDULE 13D/APSYENCE BIOMEDICAL LTD.PBM4d

   Psyence Labs Ltd acquires 1.5M shares

   • Acquired 1,497,500 Common Shares on Oct 1, 2026
   • Valuation of $8,985,000 for the shares
   • Now owns 49.75% of the company

   Psyence Labs Ltd, filed by

2. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMOct 5

   PBM partners with Benuvia for U.S. ibogaine manufacturing

   • Partnership with Benuvia for U.S. pharmaceutical-grade ibogaine production
   • Benuvia operates DEA-registered 83,000 sq ft facility in Texas
   • TIRC plans exclusive U.S. access to PsyLabs' ibogaine under term sheet
3. ROUTINESCHEDULE 13GPSYENCE BIOMEDICAL LTD.PBMOct 5

   AdvisorShares Trust reports 6.78% stake in PSYENCE BIOMEDICAL LTD.

   • 258,538 shares held
   • 6.78% of class
   • AdvisorShares Trust filed on 2026-10-05

   AdvisorShares Trust

4. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMSep 28

   Foreign issuer report

5. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMSep 23

   Foreign issuer report

6. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMSep 14

   Foreign issuer report

7. ROUTINEEFFECTPSYENCE BIOMEDICAL LTD.PBMSep 2

   Registration declared effective

8. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMAug 6

   Foreign issuer report

9. NOTABLE20-FPSYENCE BIOMEDICAL LTD.PBMJun 22

   Annual report

10. ROUTINESCHEDULE 13G/APSYENCE BIOMEDICAL LTD.PBMJun 10

    Ownership stake disclosure by Jeffrey David Weiner (amended)

    Jeffrey David Weiner, filed by

11. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMJun 5

    Foreign issuer report

12. NOTABLESCHEDULE 13DPSYENCE BIOMEDICAL LTD.PBMJun 3

    Ownership stake disclosure by Psyence Labs Ltd

    Psyence Labs Ltd, filed by

13. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMApr 23

    Foreign issuer report

14. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMApr 20

    Foreign issuer report

15. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMApr 17

    Foreign issuer report

16. ROUTINESCHEDULE 13GPSYENCE BIOMEDICAL LTD.PBMMar 2

    Ownership stake disclosure by Jeffrey David Weiner

    Jeffrey David Weiner, filed by

17. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMMar 2

    Foreign issuer report

18. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMFeb 20

    Foreign issuer report

19. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMFeb 19

    Foreign issuer report

20. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMFeb 13

    Foreign issuer report

21. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMFeb 12

    Foreign issuer report

22. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMJan 29

    Foreign issuer report

23. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMJan 27

    Foreign issuer report

24. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMJan 14

    Foreign issuer report

25. NOTABLESCHEDULE 13D/APSYENCE BIOMEDICAL LTD.PBMJan 13

    Ownership stake disclosure by Kaos Capital Ltd (amended)

    Kaos Capital Ltd, filed by

26. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMJan 13

    Foreign issuer report

27. ROUTINE6-K/APSYENCE BIOMEDICAL LTD.PBMJan 13

    Foreign issuer report (amended)

28. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMJan 8

    Foreign issuer report

29. NOTABLESCHEDULE 13DPSYENCE BIOMEDICAL LTD.PBMDec 10, 2025

    Ownership stake disclosure by Kaos Capital Ltd

    Kaos Capital Ltd, filed by

30. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMWWNov 21, 2025

    PSYENCE BIOMEDICAL LTD. filed 6-K

    • Form Type: 6-K
    • Filing Date: 2025-11-21
31. ROUTINE424B3PSYENCE BIOMEDICAL LTD.PBMWWNov 20, 2025

    PSYENCE BIOMEDICAL LTD. filed 424B3

    • Form Type: 424B3
    • Filing Date: 2025-11-20
32. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMWWNov 20, 2025

    PSYENCE BIOMEDICAL LTD. filed 6-K

    • Form Type: 6-K
    • Filing Date: 2025-11-20
33. ROUTINE424B3PSYENCE BIOMEDICAL LTD.PBMWWNov 12, 2025

    Securities offering

34. ROUTINE6-KPSYENCE BIOMEDICAL LTD.PBMWWNov 10, 2025

    Foreign issuer report

35. ROUTINE424B3PSYENCE BIOMEDICAL LTD.Nov 3, 2025

    Securities offering

Older filings on EDGAR